Element Capital Management LLC bought a new stake in Humana Inc (NYSE:HUM) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 81,545 shares of the insurance provider’s stock, valued at approximately $20,229,000. Element Capital Management LLC owned about 0.06% of Humana as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of HUM. Fieldpoint Private Securities LLC acquired a new stake in shares of Humana during the third quarter valued at $115,000. American Beacon Advisors Inc. acquired a new stake in shares of Humana during the fourth quarter valued at $122,000. ClariVest Asset Management LLC acquired a new stake in shares of Humana during the third quarter valued at $144,000. YorkBridge Wealth Partners LLC boosted its stake in shares of Humana by 99.0% during the fourth quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock valued at $159,000 after acquiring an additional 297 shares during the last quarter. Finally, Daiwa SB Investments Ltd. boosted its stake in shares of Humana by 44.9% during the fourth quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after acquiring an additional 220 shares during the last quarter. 97.85% of the stock is currently owned by institutional investors.
A number of analysts recently commented on the company. Zacks Investment Research lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday. JPMorgan Chase & Co. increased their price objective on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research note on Monday, February 12th. Deutsche Bank increased their price objective on Humana from $259.00 to $270.00 and gave the company a “hold” rating in a research note on Friday, February 9th. Jefferies Group raised Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective on the stock in a research note on Friday, January 12th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $230.00 price objective on shares of Humana in a research note on Tuesday, December 5th. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $270.47.
Shares of Humana Inc (NYSE:HUM) opened at $272.73 on Friday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.48. Humana Inc has a 52 week low of $203.48 and a 52 week high of $293.35. The stock has a market capitalization of $37,324.84, a PE ratio of 23.19, a price-to-earnings-growth ratio of 1.47 and a beta of 0.95.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The firm had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. During the same period last year, the company earned $2.34 EPS. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. equities analysts predict that Humana Inc will post 13.81 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.73%. This is an increase from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio (DPR) is 9.59%.
Humana declared that its board has approved a share repurchase program on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.
In other news, SVP Cynthia H. Zipperle sold 1,196 shares of the firm’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $273.33, for a total value of $326,902.68. Following the transaction, the senior vice president now directly owns 7,771 shares in the company, valued at approximately $2,124,047.43. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of the firm’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the transaction, the vice president now owns 11,557 shares in the company, valued at $2,843,484.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 41,775 shares of company stock worth $11,169,845. Company insiders own 0.60% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/03/17/81545-shares-in-humana-inc-hum-acquired-by-element-capital-management-llc.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.